Decentralized clinical trials (DCTs) have the ability to improve the patient trial experience, attract more diverse clinical trial participants regardless of where they reside, give greater flexibility, and reduce costs—all with the objective of bringing safe and effective therapies to market faster. To reap the many benefits of DCTs, sponsors must focus on the promise […]